安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Powering the Age of Immune Medicine - Adaptive Biotech
Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine
- Who We Are - Adaptive Biotech
A growplace Adaptive is powering immune medicine in the most unique way—and we’re looking for individuals who want to build a story, not just a resume If you want to go beyond the impossible—Adaptive is where you’ll discover your story You’ll tackle big, interesting, highly impactful problems that lead to a future you can help write
- Our Story - Adaptive Biotech
Our Innovation Timeline Just as our immune systems have evolved, shaped by our environment and biology, so has Adaptive Biotechnologies Our progress has accelerated our ability to read the immune story within each of us and apply that understanding to improve the diagnosis and treatment of disease View our timeline to see our history—from our early discoveries to our transformational
- Investor Relations | Adaptive Biotechnologies
The Investor Relations website contains information about Adaptive Biotechnologies's business for stockholders, potential investors, and financial analysts
- Adaptive Biotechnologies Reports First Quarter 2025 Financial Results . . .
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2025 “We had a strong start to 2025
- Career Listings - Adaptive Biotech
Adaptive Biotechnologies is looking for curious, passionate people with a shared desire to advance science and healthcare in their career
- Platform - Adaptive Biotech
Finding the Answers Within Us Our Immune Medicine Platform makes the adaptive immune system accessible by applying proprietary chemistry, computational biology and machine learning to read the diverse genetic code of a patient’s immune system It then generates and stores this immune receptor data in a dynamic and growing clinical database Technologies Underpinning Our Immune […]
- MRD Pipeline - Adaptive Biotech
1 Available to order as a CLIA-validated laboratory developed test (LDT) service This use has not been cleared or approved by the FDA clonoSEQ® is available as an FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies to detect minimal residual disease (MRD) in bone marrow from patients with multiple myeloma or B-cell acute lymphoblastic leukemia […]
|
|
|